A detailed history of Simplex Trading, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Simplex Trading, LLC holds 12,717 shares of NVO stock, worth $1.34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,717
Previous 117,367 89.16%
Holding current value
$1.34 Million
Previous $16.8 Million 90.96%
% of portfolio
0.05%
Previous 0.56%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $12.5 Million - $15.2 Million
-104,650 Reduced 89.16%
12,717 $1.51 Million
Q2 2024

Jul 25, 2024

SELL
$122.71 - $146.91 $8.87 Million - $10.6 Million
-72,289 Reduced 38.12%
117,367 $16.8 Million
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $11.9 Million - $15.8 Million
116,505 Added 159.27%
189,656 $24.4 Million
Q4 2023

Feb 02, 2024

BUY
$87.78 - $105.45 $723,833 - $869,540
8,246 Added 12.7%
73,151 $7.57 Million
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $5.9 Million - $13 Million
64,905 New
64,905 $5.9 Million
Q3 2022

Nov 04, 2022

BUY
$95.28 - $116.93 $914,497 - $1.12 Million
9,598 Added 314.38%
12,651 $1.26 Million
Q2 2022

Aug 03, 2022

SELL
$103.24 - $121.81 $1.64 Million - $1.94 Million
-15,891 Reduced 83.88%
3,053 $340,000
Q1 2022

May 02, 2022

SELL
$93.1 - $112.54 $484,492 - $585,658
-5,204 Reduced 21.55%
18,944 $2.1 Million
Q4 2021

Feb 23, 2022

SELL
$95.88 - $117.08 $1.02 Million - $1.25 Million
-10,669 Reduced 30.64%
24,148 $2.7 Million
Q3 2021

Oct 28, 2021

SELL
$84.42 - $106.62 $8,442 - $10,662
-100 Reduced 0.29%
34,817 $2.94 Million
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $1.41 Million - $1.77 Million
20,845 Added 148.13%
34,917 $2.92 Million
Q1 2021

Apr 26, 2021

BUY
$67.06 - $75.82 $943,668 - $1.07 Million
14,072 New
14,072 $948,000
Q3 2020

Oct 14, 2020

SELL
$63.69 - $70.22 $487,419 - $537,393
-7,653 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$58.54 - $67.94 $448,006 - $519,944
7,653 New
7,653 $501,000
Q1 2020

Apr 29, 2020

SELL
$49.46 - $64.78 $1.58 Million - $2.07 Million
-31,968 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$49.86 - $58.26 $561,623 - $656,240
11,264 Added 54.4%
31,968 $1.85 Million
Q3 2019

Oct 15, 2019

BUY
$47.54 - $53.43 $984,268 - $1.11 Million
20,704 New
20,704 $1.07 Million
Q4 2018

Jan 16, 2019

SELL
$41.54 - $47.25 $257,506 - $292,902
-6,199 Closed
0 $0
Q3 2018

Oct 23, 2018

SELL
$46.76 - $51.24 $824,519 - $903,514
-17,633 Reduced 73.99%
6,199 $292,000
Q2 2018

Jul 30, 2018

BUY
$44.29 - $50.42 $596,984 - $679,611
13,479 Added 130.19%
23,832 $1.1 Million
Q1 2018

Apr 26, 2018

BUY
$48.49 - $58.14 $364,450 - $436,980
7,516 Added 264.93%
10,353 $509,000
Q4 2017

Jan 10, 2018

BUY
$47.53 - $53.73 $134,842 - $152,432
2,837
2,837 $152,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.